Skip to content

Biomedical photopolymerization

Fromalockedspecificationtoamaterialyoucanprint,test,andstandbehind.

Voxelise helps materials teams develop hydrogels, photocurable resins, and composite photopolymers for biomedical use. You bring the application, the printer, and the constraints. You leave with cited candidates and the smallest set of experiments that are actually worth running.

  • SLA
  • DLP
  • LCD
  • related vat photopolymerization

For formulation, process, and R&D leaders in dental, medical devices, biomaterials, and bioinks. Not a chat window over papers.

A closed loop.

UTC

  1. 01State the requirement
  2. 02See what evidence already shows
  3. 03Review cited candidates
  4. 04Approve a focused campaign
  5. 05Bring the bench back in

Candidates with sources — not an unsourced answer.

Product

The literature is large. The lab is not.

A biomedical materials scientist is not trying to talk to the literature. They are trying to develop a material that prints on a named process, hits an application-specific window — mechanical, biological where it matters, optical, cost — and can be reproduced from chemicals they can actually source.

The week still looks like this: a spec arrives; evidence is scattered across papers, patents, supplier sheets, notebooks, and a senior scientist’s memory; a set of variants goes to the printer because the combinatorial space is large; something fails for a reason an abstract will not tell you; a promising candidate then faces characterization, biological evaluation where it applies, and the question of whether anyone can reconstruct why.

01

Conflicting evidence

Studies disagree because printers, wavelengths, protocols, and biological models differ. Averaging them is not science.

02

Expensive iteration

Each extra mix consumes scientist time, printer time, materials, and characterization — and can start validation too early.

03

Knowledge that walks

Recipes and failure modes live in spreadsheets and people. When they leave, the program starts again.

See how it works

A closed loop. Not a conversation that forgets Tuesday.


Voxelise is built around the material program: what you must hit, what is already known, what to try, what to measure, and what the next round should be.

  1. 01

    State the requirement

    Application, biological and mechanical targets, printer family, photochemistry, process, cost, and what you already have on the shelf.

  2. 02

    See what evidence already shows

    Literature, patents, standards, supplier data, and your own past runs — compared, not pasted into a paragraph.

  3. 03

    Review cited candidates

    Ranked formulations with risks, unknowns, and whether the evidence is likely to transfer to your printer and process.

  4. 04

    Approve a focused campaign

    A small set of runs chosen to change the decision — and a clear list of experiments not worth running yet. People sign off before anything goes to the lab.

  5. 05

    Bring the bench back in

    Results, samples, and tests update the next candidates. A recipe is a step. A material is a controlled result you can stand behind.

RequirementEvidenceCandidatesCampaignResults

Requirement → Evidence → Candidates → Campaign → Results → back

If the evidence is not there, Voxelise says so. It does not invent a citation or quietly promote a guess into a fact.

Read a written walk through the loop

Product

What sits in the program — not in a chat history.


Work is records you can open next month: requirements, materials, formulations, experiments, and reports. Conversation, when you need it, is a tool inside that work.

01

Requirements

Lock the biomedical spec: application, biology, mechanics, optics, process, chemistry, inventory, cost.

02

Evidence

Search and compare sources. Every important assertion shows where it came from.

03

Materials

Keep chemical, polymer, biomaterial, additive, and filler identity straight — including trade names and lots.

04

Formulations

Ranked candidates you can compare, duplicate, and take forward. Composition is the center of the page.

05

Process

Printer family, wavelength, exposure, layer, environment, post-cure — the window the chemistry has to live in.

06

Campaigns

Screening and confirmation plans. Failures are kept; they are how the next run gets smarter.

07

Characterization

Mechanical, physical, optical, and biological measurements where the application requires them.

08

Lineage

Formulation → print → sample → test → batch → readiness. So a later review is not archaeology.

09

Reports

Cited briefs a scientific lead or QA partner can actually read.

SLA · DLP · LCD · related vat photopolymerization

Three material families. One development loop.


The boundary is biomedical use of light-curable chemistry and photopolymerization — not all of polymer science, and not all of biotechnology.

01

Hydrogels and bioinks

Printable hydrogels and bioinks where biological performance is part of the specification, not a footnote.

02

Photocurable polymers and resins

Dental and medical resins and other photocurable systems that must print, perform, and remain reproducible.

03

Composites and filled systems

Ceramic-, glass-, nanoparticle-, fiber-, or pigment-filled photopolymers where optics, cure, and dispersion decide whether the part exists.

  • SLA
  • DLP
  • LCD
  • related vat photopolymerization

Audience

Built for the people who own the program.


  • 01Formulation scientist

    Candidates, risks, and a next-run sheet — not another unsorted PDF pile.

  • 02Biomaterials / bioink scientist

    Printability and biological performance in the same conversation, with sources.

  • 03Print process engineer

    Process windows and transfer caution, so a lab recipe does not die on the production printer.

  • 04QA and development records

    Provenance and history you can keep when someone asks “why this formula?”

  • 05VP of R&D

    Fewer low-information experiments on the way to a material that can be qualified.

IT and security get a separate, plain conversation: organizational control of recipes, experiments, and documents. Security.

Science

If it cannot be sourced, we do not pretend it can.

Scientific software that sounds fluent and cannot show its work is a liability. Voxelise is designed so a claim is only as strong as its source.

01

Source on the claim

Literature, patents, supplier data, your lab, manufacturing, regulatory text, a model, or a hypothesis — labeled in the work, not hidden in a footnote you cannot find.

02

Disagreement is visible

When studies conflict, you see both — and the practical differences (printer, wavelength, protocol, biological model). They are not averaged into one cheerful sentence.

03

People approve the lab

Ranked experiments are a recommendation. A human accepts, edits, or rejects before anything is treated as a run to execute.

04

Lab outweighs a generic paragraph

A measurement on the relevant process outranks a convenient abstract when the question is how this material behaves here.

  • Literature
  • Patent
  • Supplier
  • Lab
  • Manufacturing
  • Regulatory
  • Model
  • Hypothesis

Security

Your recipes are the work. They stay with you.


Formulations, experimental history, and documents you bring to Voxelise belong to your organization. We do not use them to advertise other customers’ success, and we do not treat private materials work as public teaching material.

  • Organizational accounts, roles, and access.
  • Private experimental history, kept separate from public scientific sources.
  • A security page written for IT, without a product tour.

Request a briefing

Bring one real program. We will walk the loop.


The useful first meeting is not a generic demo. It is a specification you already have — a dental resin, a bioink, a filled system, a printer family — and an honest look at whether Voxelise changes what you formulate or test next.

Request a briefing

FAQ

Questions we are asked


No. Chat can exist inside a program. The work is the requirement, the evidence, the candidates, the campaign, and the results.

No. Voxelise is the scientific layer for biomedical photopolymerization: evidence, formulation, experiments, and lineage. It is meant to sit beside the systems you already keep records in.

Biomedical applications of photopolymerization — hydrogels and bioinks, photocurable resins, and composites — on DLP, SLA, LCD, and related vat processes. We do not try to be software for all of materials science.

It can recommend a focused set of experiments. Your team approves before anything is treated as a campaign to execute.

Conflicts stay visible, with the differences that usually explain them. We do not hide disagreement behind a single answer.

Yes. Your history is often the most valuable evidence in the building. It stays in your organization.

No universal percentage. The aim is fewer low-information runs and a higher chance that each selected experiment changes the decision, measured on your program.

Materials and formulation teams in photopolymer, dental, medical device, biomaterials, and bioink organizations — and materials groups inside printer companies — who already develop or intend to develop named biomedical materials.

Request a briefing. This is expert software, introduced with a real program, not a self-serve chat trial.